FLT3 and acute myeloid leukemia: Particularly, FLT3-ITD mutated AML cases may be susceptible for metformin and maybe with enhanced efficiency when combined with the kinase inhibitor sorafenib or the experimental drug 6-benzoylthioinosine (70, 71).